Responses
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
83 The prognostic significance of peripheral blood biomarkers in patients with advanced non-small cell lung cancer treated with pembrolizumab: a clinical study
Compose a Response to This Article
Other responses
No responses have been published for this article.
